
Green Thumb Industries has submitted applications to the U.S. Drug Enforcement Administration (DEA) to register its state-licensed medical cannabis operations following the recent rescheduling of medical marijuana to Schedule III. This change is significant as it opens opportunities for more research, improved tax treatment, and federal normalization of the cannabis industry. Green Thumb operates over 110 retail locations across 14 U.S. markets and will discuss this milestone along with its Q1 2026 financial results on May 6. The DEA registration marks a key step toward a regulated federal cannabis market in the U.S.